⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDWD News
MediWound Ltd.
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
globenewswire.com
VCEL
MDWD
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
globenewswire.com
MDWD
VCEL
MediWound Files Annual Report on Form 20-F
globenewswire.com
MDWD
MediWound Files Annual Report on Form 20-F
globenewswire.com
MDWD
MediWound Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
MDWD
MediWound to Report Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
MDWD
MediWound to Present at Upcoming Investor Conferences
globenewswire.com
MDWD
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
globenewswire.com
MDWD
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
globenewswire.com
MDWD
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
MDWD